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a B s t R a C t
We present a case of an acute myocardial infarction with ST segment elevation in a 
patient with a mechanical aortic valve prosthesis who had discontinued anticoagulant 
therapy. We swiftly performed a primary coronary intervention procedure, including 
thrombus aspiration as well as plain balloon angioplasty (low atmospheres), in order 
to restore coronary flow in the left anterior descending coronary artery. Review of the 
literature suggests that in such cases the diagnosis of the embolic origin of the acute 
coronary syndrome is assumed and can never been proved definitely. Thrombus aspi-
ration must be included in the therapeutic strategy of these patients.
C a s e  p R e s e n t a t i o n
A 30-year-old male with a bileaflet mechanical aortic valve (St Jude Medical 
Standard, 23 mm), implanted for stenosis of a bicuspid aortic valve two years ago, 
was admitted because of an anterior acute myocardial infarction with ST segment 
elevation (Figure 1). The patient did not have any conventional risk factor for coro-
nary artery disease; never had he smoked, had no diabetes mellitus or hypertension 
or hypercholesterolemia, and his body mass index was 28 kg/m2. He reached the 
emergency department 90 minutes after the onset of chest pain. On admission, after 
a rapid clinical evaluation and recording of an ECG (Figure 1), a transthoracic echo-
cardiographic examination was performed which revealed marked hypokinesis of the 
anterior and septal wall of the left ventricle, left ventricular ejection fraction of 45% 
and a normally functioning aortic valve without any apparent thrombus (Figure 2A) 
and with an acceptable transvalvular peak gradient (23 mmHg) for the specific type 
of metallic aortic valve (Figure 2B). Although he was supposed to have been receiving 
warfarin, surprisingly, INR was found to be 1. The patient admitted that he had on 
his own discontinued warfarin 15 days earlier.
The patient was immediately placed on aspirin 500 mg and clopidogrel 600 mg 
per os. He also received intravenous eptifibatide, a platelet glycoprotein IIbIIIa in-
hibitor, in a bolus dosage followed by continuous infusion at a maintenance dosage 
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FiguRe 1. Admission 12-lead ECG indicating acute anterior ST elevation myocardial infarction.
FiguRe 2. Transthoracic echocardiography study (a, long axis parasternal view) showing no apparent thrombus on the metallic 
aortic valve, while a Doppler study (B) indicated an acceptable transoartic gradient for the specific type of prosthesis.
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before his transfer to the catheterization laboratory 30 min-
utes later. Fluoroscopy documented normal opening of both 
leaflets of the mechanical aortic valve (Figure 3). Coronary 
angiogram showed total occlusion in the mid segment of the 
left anterior descending coronary artery (LAD) (Figure 4A). 
After administration of adjusted unfractionated heparin in 
a bolus infusion (70 IU/kg), we proceeded to perform coro-
nary angioplasty. Initially it was attempted to restore vessel 
flow with a transcatheter thrombus removal system (Export 
Catheter, Medtronic). However, thrombus aspiration proved 
partially successful in restoring LAD flow, and only very 
small pieces of thrombotic material were recovered (Figure 5). 
Subsequently, we inflated a small (2 x 10 mm) balloon (Figure 
4B) at low pressure (6 atmospheres), relieving the obstruction 
and achieving a TIMI II flow. Since the obstructive lesion in 
the LAD was attributed to coronary embolus, no stent was 
implanted, in order to avoid any restenosis as a result of vessel 
trauma and also to obviate the need for double antiplatelet 
therapy which combined with warfarin therapy, necessary for 
his artificial valve, might significantly increase the bleeding 
risk. Considering a pathophysiology of partial no-reflow phe-
nomenon, repeated doses of 50 mcg of intracoronary adenosine 
to a total dosage of 200 mcg were administered. Eventually an 
open vessel with restored TIMI III flow was obtained (Figure 
4C) and the patient had complete relief of anginal symptoms. 
A door-to-balloon inflation time of approximately 50 minutes 
was achieved and the total duration of myocardial ischemia 
was estimated at 140 minutes.
Twelve hours after sheath removal, the patient was started 
on warfarin; he was bridged with subcutaneous enoxaparin 
(1 IU/kg) twice daily until the INR was stabilized at values 
>2 for the subsequent three days. Eptifibatide continuous 
infusion was maintained for 24 hours. Postprocedurally, the 
patient was started and maintained on aspirin 100 mg daily, 
carvedilol 6.25 mg bid and enalapril 10 mg daily. Serum levels 
of biochemical markers of myocardial damage were indica-
tive of an extensive myocardial infarction; CK-MB peaked at 
115 U/L and the troponin I level at 65 ng/ml. The patient did 
FiguRe 3. Fluoroscopic view of the two leaflets of the aortic 
prosthesis showed normal opening of the artificial valve.
FiguRe 4. Angiographic views indicating the total obstruction of the left anterior descending (LAD) coronary artery (a, arrow), 
which was relieved with use of an aspiration catheter (not shown) and a plain angioplasty balloon (B), which restored flow to the 
LAD (C).
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well clinically and was discharged 6 days later. On the day of 
discharge, an echocardiography study showed that the left 
ventricular ejection fraction remained at 45% and there was 
still hypokinesis of the anterior and septal walls.
Due to the absence of any detectable thrombi on the me-
tallic aortic valve by serial transthoracic echocardiographic 
studies and the fluoroscopic documentation of a normally 
functioning aortic prosthetic valve, a transesophageal echo-
cardiogram was not performed either at presentation, or after 
the procedure.
D i s C u s s i o n
Since the advent of prosthetic valvular surgery, another 
source for coronary emboli has been introduced, and fragments 
of the prosthetic material or more commonly thrombus formed 
at the surface of the prosthesis may constitute the embolic 
material.2 In 1964, Bjork and Malers,3 on discussing the late 
results of mitral valve replacement, reported the first case of 
coronary embolism arising from a mitral prosthesis.
Despite technical improvement in prosthesis design and 
the development of less thrombogenic material, mechanical 
valve prostheses still carry a significant thromboembolic risk, 
which warrants long-term anticoagulation therapy. However, 
even adequate anticoagulation therapy does not eliminate 
the risk of thromboembolism in these patients. Type of valve, 
position and associated conditions affect the risk of thrombo-
embolism. Patients with caged ball or tilting disk valves have a 
higher risk as compared to patients with bileaflet valves (2.5% 
/year vs 0.5% /year respectively). A mechanical valve in the 
aortic position has a lower risk (0.5%/year) as compared to 
mitral valve (0.9%/year) or both (1.2%/year). From this point 
of view, our patient had a favorable profile (bileaflet valve, 
aortic position) to avoid an episode of thromboembolism, but 
unfortunately he had a myocardial infarction 15 days after 
discontinuing anticoagulant therapy. A case has been reported 
in the literature of a patient with a metallic aortic valve who 
was scheduled for stripping of a lower limb varix and had in-
terrupted anticoagulant therapy for only 3 days, who suffered 
an acute myocardial infarction postoperatively.5 On the other 
hand, another interesting case6 of coronary embolism causing 
myocardial infarction in a patient with mechanical aortic valve 
prosthesis who had previously quit warfarin for almost a year 
has also been reported.
In cases of coronary embolization and myocardial infarc-
tion a source of thrombotic material is usually detected.7-9 It is 
noteworthy that acute myocardial infarction due to coronary 
embolism can occur as a result of left atrial thrombus in cases 
of atrial fibrillation.9 Echocardiography is a very useful tool 
in diagnosing a thrombus on a mechanical valve prosthesis, 
although differential diagnosis from panus is usually a difficult 
challenge. But in some cases,10,11 as in the present case, no ap-
parent thrombus could be detected. In such cases a definite 
proof of an embolic pathophysiology cannot be documented 
and rather remains a presumptive diagnosis. Although we 
documented the presence of thrombus at the site of arterial 
occlusion, this is not proof of the embolic origin of acute myo-
cardial infarction, since the thrombotic process is very common 
in acute coronary syndromes in patients with atherosclerotic 
coronary artery disease. Our assumption regarding embolic 
pathophysiology in this case was based on the predisposing 
factors for thrombosis (mechanical valve and interruption of 
anticoagulant therapy), and the low probability for coronary 
artery disease in this patient. The patient was very young 
with very low probability for myocardial infarction, but with 
very high probability for any embolic event since he was not 
receiving any anticoagulation therapy at all. From this point 
of view, we considered that myocardial infarction could prob-
ably be attributed to embolization of microthrombi from the 
mechanical valve to the LAD. On the other hand, even in 
cases with an apparent thrombus formation, this does not 
constitute proof for a causative relationship with an occluded 
coronary artery.
Treatment of acute myocardial infarction due to embo-
lization includes many therapeutic alternatives, both drugs 
and interventional procedures. A case has been described of 
percutaneous transluminal coronary recanalization9 attempted 
by infusing 1.2 million units of urokinase which however proved 
unsuccessful. Nevertheless, repeat coronary angiography per-
formed 40 days later, showed normal coronary arteries. Another 
case of coronary embolism with suboptimal INR levels, was 
successfully treated with percutaneous transluminal coronary 
angioplasty and stenting,10 whereas in another relevant case 
an aspiration catheter (Export XT, Medtronic) was only used 
and succeeded in restoring coronary flow without stenting.11 
FiguRe 5. Here is shown (within the basket) the thrombotic 
(red) material which was retrieved with use of the aspiration 
catheter from the site of the total occlusion of the LAD. 
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Although thrombus aspiration has been proved to be an ef-
fective method12 in treating acute myocardial infarction due to 
coronary embolism, in the case presented herein, the aspiration 
device failed to restore flow in the occluded vessel. Adjunctive 
therapy with infusion of a platelet glycoprotein IIbIIIa inhibitor 
may be effective in reducing thrombotic burden and eliminat-
ing the risk of the no-reflow phenomenon when angioplasty is 
performed. In these cases the IIbIIIa agent should be started 
as soon as possible even before transferring the patient to 
the catheterization laboratory. It is noteworthy that coronary 
embolism in a patient with mitral valve prosthesis13 has been 
successfully treated with the IIbIIIa agent, tirofiban, and half 
a dose of tissue-type plasminogen activator.
In patients with a presumed embolic coronary event,14 
transesophageal echocardiography (TEE) has been recom-
mended to identify any potential endocardial source of emboli. 
In the present case, TEE was not performed and this may be 
a limitation, however, it is known that even TEE has a very 
low sensitivity in documenting presence of microthrombi 
on a metallic valve, as increased echogenicity hinders good 
visualization. Removal of microthrombotic material from the 
LAD supports the hypothesis that acute myocardial infarc-
tion in this case was presumably due to embolization from the 
mechanical aortic valve prosthesis in a non-compliant patient 
who was not receiving anticoagulation prophylaxis for the 
preceding 2 weeks. From this point of view, it was considered 
that further exclusion of a paradoxic origin of such an embo-
lization was not necessary, since additionally, transthoracic 
echocardiography had not revealed any apparent intracardiac 
communication.
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